Αρχειοθήκη ιστολογίου

Παρασκευή 8 Σεπτεμβρίου 2017

ESMO 2017: taselisib boosts breast tumour shrinkage in LORELEI trial

Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both oestrogen receptor positive and HER2-negative (ER /HER2-) according to results of the LORELEI trial, presented at the ESMO...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wMLdQU
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader